Financial results - DOPHARMA INVEST S.R.L.

Financial Summary - Dopharma Invest S.r.l.
Unique identification code: 22279985
Registration number: J35/3079/2007
Nace: 6810
Sales - Ron
-
Net Profit - Ron
-339
Employees
Open Account
Company Dopharma Invest S.r.l. with Fiscal Code 22279985 recorded a turnover of 2024 of - , with a net profit of -339 and having an average number of employees of - . The company operates in the field of Cumpararea si vanzarea de bunuri imobiliare proprii having the NACE code 6810.
Sales - Ron

Sales, Profit, Employees, Total Income, Financial Results - Dopharma Invest S.r.l.

2015 2016 2017 2018 2019 2020 2021 2022 2023 2024
Sales - EUR 0 0 0 0 0 0 0 - 0 0
Total Income - EUR 17.240 9.414 733 4 1.418 0 0 - 136 58
Total Expenses - EUR 22.960 12.211 15.307 898 13.396 428 23.443 - 3.741 397
Gross Profit/Loss - EUR -5.720 -2.797 -14.575 -894 -11.978 -428 -23.443 - -3.605 -339
Net Profit/Loss - EUR -5.720 -2.797 -14.575 -894 -11.978 -428 -23.443 - -3.605 -339
Employees 0 0 0 0 0 0 0 - 0 0
The table presents the most important indicators of the company from the Profit and Loss Account for the last 10 years of activity as found at the Ministry of Finance. The data provides the evolution of the company during this period regarding the increases and possibly decreases recorded.
Sales - Ron
Net Profit - Ron
Employees

Check the financial reports for the company - Dopharma Invest S.r.l.

Rating financiar

Financial Rating -
DOPHARMA INVEST S.R.L.

See the company's note based on the submitted financial data, relative to the industry of which it is a part.

Financial Rating
Limite de plata

Payment Limits -
Dopharma Invest S.r.l.

See the company's payment capacity for situations in which you conclude contracts with payment terms.

Check Payment Limits
Probabilitate de insolventa

Prob. of insolvency -
Dopharma Invest S.r.l.

It determines the risk of insolvency based on the submitted accounting balance.

Insolvency Probability
Rapoarte financiare

Financial Reports -
Dopharma Invest S.r.l.

Check all the financial reports of the company and know the risks in collaboration with it.

Check Financial Reports
Financial Analysis Reports provide a clear and comprehensive view of a company's financial activity. In addition to presenting financial data, the reports analyze this data so that any user can understand whether the results are positive or less favorable. The Financial Rating provides an analysis based on the most important financial ratios, including liquidity, solvency, and profitability. Payment Limits represent the maximum amounts for which a company can offer goods or services on credit to its clients. The Probability of Insolvency presents the theoretical probability that a company may not be able to meet its financial obligations towards its creditors, i.e., suppliers and financial institutions.

Debts, Equity, Inventories, Receivables, Accounts, Assets - Dopharma Invest S.r.l. - CUI 22279985

2015 2016 2017 2018 2019 2020 2021 2022 2023 2024
Fixed Assets 428.229 423.862 416.690 409.043 401.121 393.517 384.790 - 384.814 382.663
Current Assets 21.100 20.325 20.335 19.587 17.795 17.030 16.108 - 16.815 16.324
Inventories 0 0 0 0 0 0 0 - 0 0
Receivables 3.636 3.600 3.540 3.476 3.410 3.346 3.274 - 3.278 3.261
Cash 17.464 16.725 16.795 16.111 14.386 13.684 12.835 - 13.536 13.063
Shareholders Funds -137.012 -138.411 -150.644 -148.773 -157.870 -155.305 -175.304 - -177.738 -177.083
Social Capital 7.147 7.074 6.955 6.827 6.695 6.568 6.422 - 6.423 6.387
Debts 586.341 582.598 587.668 577.402 576.787 565.852 576.202 - 579.366 576.070
Income in Advance 0 0 0 0 0 0 0 - 0 0
Exchange rate - RON 4.9743 4.9465 4.9315 4.9468 4.8371 4.7454 4.6535 4.5681 4.4908 4.445
Main CAEN "6810 - 6810"
CAEN Financial Year 6810
The table presents the company's Balance Sheet structure for the last 10 years. Current Assets recorded a value of 16.324 euro in 2024 which includes Inventories of 0 euro, Receivables of 3.261 euro and cash availability of 13.063 euro.
The company's Equity was valued at -177.083 euro, while total Liabilities amounted to 576.070 euro. Equity decreased by -339 euro, from -177.738 euro in 2023, to -177.083 in 2024.

Risk Reports Prices

Reviews - Dopharma Invest S.r.l.

Comments - Dopharma Invest S.r.l.

Similar services useful for checking companies and business development.

SellNet

Get the contact details for any company and get in touch with it.

Sectoral Studies

Knows the market and develops its own development strategies according to sectorial data.

Databases

Export in excel files the data of the companies selected according to the desired criteria.

Import - Export

Find importers and exporters according to the type of activity and the countries in which they carry it out.

Similar services represent services associated with companies that allow for a better analysis of clients and suppliers. Company Contacts help you get in touch with the desired companies. Sector Studies provide an overview of an industry, the most important competitors, and the geographical distribution of companies. Company Lists allow you to attract new clients, while Import-Export services give you access to companies engaged in such activities.